National Cancer Institute
U.S. National Institutes of Health |

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
About NCI
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights

call now for more information . . . 1-800-4-CANCER
Digital Mammographic Imaging Screening Trial

Find Participating Screening Centers
DMIST Updates
Breast Cancer Home Page

DMIST, the Digital Mammographic Imaging Screening Trial, is a research study sponsored by the U.S. National Cancer Institute.

what is DMIST?

In late 2003, the Digital Mammographic Imaging Screening Trial (DMIST) reached its target goal of enrolling 49,500 women in the United States and Canada. DMIST is now closed to further enrollment while researchers analyze the results.

Initial results from the trial were released from the American College of Radiology Imaging Network (ACRIN) on Sept. 16, 2005 (see the press release) and published in a special online edition of the New England Journal of Medicine that day.

Each study participant had both a digital and coventional screen-film mammogram performed at the time of enrollment, and was asked to return one year later for a follow-up mammogram. The follow-up exam is critical because it will allow researchers to assess each participant's breast health and gather key data for comparing the two technologies.

more info

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health